Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma.

Aaron J QuynShilpa MurthyLaura GouldHager SaidJim TiernanPeter SagarAnthony AntoniouIan JenkinsElaine M Burns

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)

Complete R0 resection for recurrent or persistent anal SCC is possible in the majority of patients and improves overall and disease-free survival compared with R1/R2 resection.

Keyphrases

free survival
squamous cell carcinoma
end stage renal disease
rectal cancer
ejection fraction
minimally invasive
newly diagnosed
chronic kidney disease
high grade
prostate cancer
skeletal muscle
weight loss